AAIS
PFE icon

ABN AMRO Investment Solutions’s Pfizer PFE Stock Holding History

ABN AMRO Investment Solutions’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.84M Buy
366,987
+53,193
+17% +$1.39M 0.08% 168
2026
Q1 		$8.81M Buy
313,794
+33,262
+12% +$886K 0.11% 146
2025
Q4 		$6.99M Buy
280,532
+208,172
+288% +$5.25M 0.1% 162
2025
Q3 		$1.84M Sell
72,360
-1,243
-2% -$30.7K 0.04% 255
2025
Q2 		$1.78M Buy
73,603
+2,222
+3% +$51.8K 0.04% 256
2025
Q1 		$1.81M Sell
71,381
-4,750
-6% -$124K 0.04% 255
2024
Q4 		$2.02M Sell
76,131
-5,264
-6% -$143K 0.04% 254
2024
Q3 		$2.36M Buy
81,395
+4,244
+6% +$124K 0.04% 247
2024
Q2 		$2.16M Buy
77,151
+46,255
+150% +$1.27M 0.04% 243
2024
Q1 		$857K Buy
30,896
+4,557
+17% +$126K 0.01% 307
2023
Q4 		$758K Sell
26,339
-794
-3% -$24K 0.01% 314
2023
Q3 		$900K Buy
27,133
+679
+3% +$24K 0.02% 298
2023
Q2 		$970K Sell
26,454
-809
-3% -$31.5K 0.02% 286
2023
Q1 		$1.11M Buy
+27,263
New +$1.18M 0.02% 299

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ABN AMRO Investment Solutions's PFE Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its Pfizer (PFE) stake by 17% in Q2 2026, buying an estimated $1.39M and bringing the position to 366,987 shares worth $8.84M. The position accounts for 0.08% of the portfolio, ranked #168.

ABN AMRO Investment Solutions first reported a position in PFE in Q1 2023 and has held it in 14 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • ABN AMRO Investment Solutions held 366,987 shares of Pfizer worth $8.84M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 53,193 Pfizer shares in Q2 2026, an estimated $1.39M.
  • Pfizer made up 0.08% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #168 holding.
  • ABN AMRO Investment Solutions first reported a position in Pfizer in Q1 2023 and has held it in 14 quarters since.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.